• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脯氨酰羟化酶3抑制胃癌细胞的致瘤性。

Prolyl hydroxylase 3 inhibited the tumorigenecity of gastric cancer cells.

作者信息

Cui Lei, Qu Jianguo, Dang Shengchun, Mao Zhengfa, Wang Xuqing, Fan Xin, Sun Kang, Zhang Jianxin

机构信息

General Surgery Department, Affiliated Hospital of Jiangsu University, Zhenjiang City, Jiangsu Province, China.

出版信息

Mol Carcinog. 2014 Sep;53(9):736-43. doi: 10.1002/mc.22025. Epub 2013 Mar 26.

DOI:10.1002/mc.22025
PMID:23533015
Abstract

Gastric cancer is one of the most common malignancies and the second leading cause of cancer-related death in the world, and it is very urgent to develop novel therapeutic strategies. Although HIF-1α is the most highly characterized target of prolyl hydroxylase 3 (PHD3), PHD3 has been shown to regulate several signal pathways independent of HIF-1α. Here, we found that the expression of PHD3 was decreased in the clinical gastric cancer samples and reversely correlated with tumor size and tumor stage. Over-expression of PHD3 in the gastric cancer cells significantly inhibited cell growth in vitro and in vivo, while knockdown the expression of PHD3 promoted the tumorigenecity of gastric cancer cells. Mechanistically, it showed that PHD3 downregulated the expression of beta-catenin and inhibited beta-catenin/T-cell factor (TCF) signaling. Taken together, our findings demonstrate that PHD3 inhibits gastric cancer by suppressing the beta-catenin/TCF signaling and PHD3 might be an important therapeutic target in gastric cancer.

摘要

胃癌是世界上最常见的恶性肿瘤之一,也是癌症相关死亡的第二大主要原因,因此开发新的治疗策略迫在眉睫。虽然缺氧诱导因子-1α(HIF-1α)是脯氨酰羟化酶3(PHD3)最具特征的靶点,但已证明PHD3可独立于HIF-1α调节多种信号通路。在此,我们发现临床胃癌样本中PHD3的表达降低,且与肿瘤大小和肿瘤分期呈负相关。在胃癌细胞中过表达PHD3可显著抑制体外和体内细胞生长,而敲低PHD3的表达则促进胃癌细胞的致瘤性。机制上,结果表明PHD3下调β-连环蛋白的表达并抑制β-连环蛋白/T细胞因子(TCF)信号传导。综上所述,我们的研究结果表明,PHD3通过抑制β-连环蛋白/TCF信号传导来抑制胃癌,并且PHD3可能是胃癌的一个重要治疗靶点。

相似文献

1
Prolyl hydroxylase 3 inhibited the tumorigenecity of gastric cancer cells.脯氨酰羟化酶3抑制胃癌细胞的致瘤性。
Mol Carcinog. 2014 Sep;53(9):736-43. doi: 10.1002/mc.22025. Epub 2013 Mar 26.
2
Prolyl-hydroxylase PHD3 interacts with pyruvate dehydrogenase (PDH)-E1β and regulates the cellular PDH activity.脯氨酰羟化酶 PHD3 与丙酮酸脱氢酶(PDH)-E1β 相互作用,调节细胞 PDH 活性。
Biochem Biophys Res Commun. 2014 Aug 22;451(2):288-94. doi: 10.1016/j.bbrc.2014.07.114. Epub 2014 Aug 1.
3
Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.脯氨酰羟化酶-3 在结直肠癌细胞中下调,并抑制 IKKβ,而不依赖于羟化酶活性。
Gastroenterology. 2010 Feb;138(2):606-15. doi: 10.1053/j.gastro.2009.09.049. Epub 2009 Sep 26.
4
Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.脯氨酰羟化酶3的抑制改善糖尿病性心肌病中的心脏功能障碍。
Mol Cell Endocrinol. 2015 Mar 5;403:21-9. doi: 10.1016/j.mce.2015.01.014. Epub 2015 Jan 13.
5
Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.肝内胆绿素还原酶A通过抑制上皮-间质转化抑制胰腺癌转移
Oncotarget. 2015 Jun 30;6(18):16168-82. doi: 10.18632/oncotarget.3753.
6
Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.Krüppel 样因子 4 负向调节 β-连环蛋白的表达,抑制胃癌的增殖、侵袭和转移。
Int J Oncol. 2012 Jun;40(6):2038-48. doi: 10.3892/ijo.2012.1395. Epub 2012 Mar 7.
7
Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.脯氨酰羟化酶 3 通过非羟化酶依赖的方式抑制 p53-MDM2 相互作用稳定抑癌蛋白 p53。
J Biol Chem. 2019 Jun 21;294(25):9949-9958. doi: 10.1074/jbc.RA118.007181. Epub 2019 May 15.
8
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.PHD3 通过 TGFα 控制肺癌转移和对 EGFR 抑制剂的耐药性。
Cancer Res. 2018 Apr 1;78(7):1805-1819. doi: 10.1158/0008-5472.CAN-17-1346. Epub 2018 Jan 16.
9
HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.缺氧诱导因子-1α 是通过自然转移途径在硬癌型胃癌中发生腹膜扩散的关键因素。
Int J Oncol. 2013 Nov;43(5):1431-40. doi: 10.3892/ijo.2013.2068. Epub 2013 Aug 21.
10
APC-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma.APC 介导的 PHD3 降解稳定 HIF-1a 并促进肝癌发生。
Cancer Lett. 2021 Jan 1;496:144-155. doi: 10.1016/j.canlet.2020.10.011. Epub 2020 Oct 9.

引用本文的文献

1
PHD3 inhibits colon cancer cell metastasis through the occludin-p38 pathway.PHD3 通过封闭蛋白-p38 通路抑制结肠癌细胞转移。
Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1749-1757. doi: 10.3724/abbs.2023103.
2
Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly.胃肠道癌症中的生物能量改变:好的、坏的和丑的。
World J Gastroenterol. 2023 Aug 7;29(29):4499-4527. doi: 10.3748/wjg.v29.i29.4499.
3
Circ_101341 Deteriorates the Progression of Clear Cell Renal Cell Carcinoma Through the miR- 411/EGLN3 Axis.
Circ_101341通过miR-411/EGLN3轴促进肾透明细胞癌进展。
Cancer Manag Res. 2020 Dec 31;12:13513-13525. doi: 10.2147/CMAR.S272287. eCollection 2020.
4
Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.脯氨酰羟化酶-3 是一种新型的肾细胞癌标志物。
Investig Clin Urol. 2019 Nov;60(6):425-431. doi: 10.4111/icu.2019.60.6.425. Epub 2019 Oct 1.
5
Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.脯氨酰羟化酶 3 通过非羟化酶依赖的方式抑制 p53-MDM2 相互作用稳定抑癌蛋白 p53。
J Biol Chem. 2019 Jun 21;294(25):9949-9958. doi: 10.1074/jbc.RA118.007181. Epub 2019 May 15.
6
Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma.PHD3和HIF2α基因表达与人类肝细胞癌临床病理特征的相关性
Oncol Lett. 2018 Jan;15(1):545-551. doi: 10.3892/ol.2017.7302. Epub 2017 Oct 31.
7
Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.脯氨酰羟化酶结构域蛋白3和抑制缺氧诱导因子-1水平的天冬酰胺酰羟化酶因子可预测肝细胞癌的肿瘤行为和预后。
Oncotarget. 2017 Feb 21;8(8):12983-13002. doi: 10.18632/oncotarget.14677.